Status:
COMPLETED
An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
COVID 19
Eligibility:
All Genders
18-75 years
Brief Summary
The current outbreak of COVID-19 pandemic has been marked by severe psychological problems. People around the world experienced a similarly frightening public health emergency, on a global scale, with...
Detailed Description
* As the Indian Government recommended the public to minimize face-to-face interaction and isolate them at home, potential respondents will be invited through a text message which will lead to a surve...
Eligibility Criteria
Inclusion
- \- Patients who have shown at Institute of Liver \& Biliary Sciences (ILBS) between 1st January 2018 and 31st March 2020 will be considered as currently being enrolled at ILBS for treatment.
Exclusion
- \- Incomplete questionnaires
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
347 Patients enrolled
Trial Details
Trial ID
NCT04352491
Start Date
April 24 2020
End Date
May 31 2020
Last Update
June 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India, 110070